Alps Advisors Inc Ironwood Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 117,535 shares of IRWD stock, worth $414,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,535

Previous 123,975 5.19%

Holding current value

$414,898

Previous $808,000 40.22%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.93 - $7.04 $25,309 - $45,337	-6,440 Reduced 5.19%	117,535 $483,000
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $75,715 - $116,829	13,569 Added 12.29%	123,975 $808,000
Q1 2024 May 14, 2024	BUY	$8.32 - $15.45 $25,825 - $47,956	3,104 Added 2.89%	110,406 $961,000
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $68,887 - $90,203	-7,837 Reduced 6.81%	107,302 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $76,972 - $105,895	-9,330 Reduced 7.5%	115,139 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $1.26 Million - $1.44 Million	124,469 New	124,469 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $161,449 - $197,114	-15,922 Reduced 15.99%	83,628 $866,000
Q2 2022 Aug 11, 2022	BUY	$11.05 - $12.72 $1.1 Million - $1.27 Million	99,550 New	99,550 $1.15 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $330,130 - $400,761	-31,115 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$10.86 - $13.95 $6,754 - $8,676	622 Added 2.04%	31,115 $363,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $363,476 - $424,462	30,493 New	30,493 $398,000
Q2 2021 Aug 11, 2021	SELL	$10.16 - $13.11 $2.96 Million - $3.82 Million	-291,213 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$9.04 - $11.86 $18,541 - $24,324	2,051 Added 0.71%	291,213 $3.26 Million
Q4 2020 Feb 03, 2021	BUY	$9.05 - $12.2 $609,128 - $821,145	67,307 Added 30.34%	289,162 $3.29 Million
Q3 2020 Nov 04, 2020	BUY	$8.99 - $10.74 $39,753 - $47,492	4,422 Added 2.03%	221,855 $2 Million
Q2 2020 Aug 05, 2020	SELL	$9.14 - $11.97 $618,476 - $809,973	-67,667 Reduced 23.73%	217,433 $2.24 Million
Q1 2020 May 06, 2020	SELL	$8.58 - $14.01 $263,817 - $430,779	-30,748 Reduced 9.74%	285,100 $2.88 Million
Q4 2019 Feb 07, 2020	BUY	$8.22 - $14.0 $2.6 Million - $4.42 Million	315,848 New	315,848 $4.2 Million
Q4 2018 Feb 04, 2019	SELL	$7.8 - $16.13 $1.92 Million - $3.97 Million	-246,297 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$14.31 - $17.65 $678,294 - $836,609	47,400 Added 23.83%	246,297 $4.55 Million
Q2 2018 Aug 02, 2018	BUY	$11.83 - $16.2 $578,096 - $791,645	48,867 Added 32.57%	198,897 $3.8 Million
Q2 2018 Jul 25, 2018	SELL	$11.83 - $16.2 $373,354 - $511,272	-31,560 Reduced 17.38%	150,030 $2.25 Million
Q1 2018 May 01, 2018	BUY	$11.13 - $13.63 $351,262 - $430,162	31,560 Added 21.04%	181,590 $2.8 Million
Q4 2017 Feb 05, 2018	BUY	$12.16 - $14.58 $206,841 - $248,005	17,010 Added 12.79%	150,030 $2.25 Million
Q3 2017 Nov 03, 2017	BUY	$12.07 - $14.87 $1.61 Million - $1.98 Million	133,020	133,020 $2.1 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Ironwood Pharmaceuticals Inc Transaction History